Supplementary protection certificate for medicinal products. Recast
Supplementary protection certificate for medicinal products (recast)
- Stage
- EP position adopted, reached 28 Feb 2024
- Procedure
- OLP · Ordinary legislative procedure
- Rapporteur
- Tiemo Wölken (S&D)
- Lead DG
- DG GROW
- Commissioner
- Stéphane Séjourné
- Council configuration
- Competitiveness Council
- Last activity
- 4 Sept 2026
- Legal basis
- TFEU_2016 Art. 114; TFEU_2016 Art. 114(1); TFEU_2016 Art. 294
Where it stands
Latest: Deliberations in Council working party, 4 Sept 2026.
ShowHide the earlier record: 39 dates, 27 Apr 2023 to 31 Mar 2026
- 27 Apr 2023
- Adoption of legislative proposal by the Commission
- 28 Apr 2023
- Discussions within the Council or its preparatory bodies
- 14 Jul 2023
- Discussions within the Council or its preparatory bodies
- 11 Sept 2023
- Referred to committee
- 25 Sept 2023
- Discussions within the Council or its preparatory bodies
- 13 Oct 2023
- Committee report tabled
- EP committee draft report
- 16 Oct 2023
- Discussions within the Council or its preparatory bodies
- 7 Nov 2023
- Committee opinion adopted
- 14 Nov 2023
- Committee amendments tabled
- Tabling of amendments in the EP committee responsible
- 24 Jan 2024
- Committee report adopted
- 1 Feb 2024
- Discussions within the Council or its preparatory bodies
- Tabled for plenary
- 27 Feb 2024
- Debate in plenary
- 28 Feb 2024
- EP position at first reading
- Plenary amended the proposal
- Plenary vote
- 2 Jul 2024
- Discussions within the Council or its preparatory bodies
- 11 Jul 2024
- Discussions within the Council or its preparatory bodies
- 13 Nov 2024
- Referred to committee
- 28 Nov 2024
- Deliberations in Council
- 18 Dec 2024
- Deliberations in Coreper
- 10 Apr 2025
- Deliberations in Council working party
- 28 Apr 2025
- Deliberations in Council working party
- 8 May 2025
- Deliberations in Council working party
- 2 Jun 2025
- Deliberations in Council working party
- 3 Jun 2025
- Deliberations in Council working party
- 23 Jun 2025
- Deliberations in Council working party
- 2 Jul 2025
- Deliberations in Council working party
- 3 Jul 2025
- Deliberations in Council working party
- 5 Sept 2025
- Deliberations in Council working party
- 3 Oct 2025
- Deliberations in Council working party
- 20 Oct 2025
- Deliberations in Council working party
- 21 Oct 2025
- Retained as a pending proposal in the Commission work programme · Commission
- 3 Nov 2025
- Deliberations in Council working party
- 17 Nov 2025
- Deliberations in Council working party
- 5 Dec 2025
- Deliberations in Council working party
- 8 Dec 2025
- Deliberations in Council
- 21 Jan 2026
- Deliberations in Council working party
- 6 Feb 2026
- Deliberations in Council working party
- 18 Feb 2026
- Deliberations in Council working party
- 18 Mar 2026
- Deliberations in Council working party
- 31 Mar 2026
- Deliberations in Council working party
- 27 Apr 2026
- Deliberations in Council working party
- 22 May 2026
- Deliberations in Council working party
- 27 May 2026
- Deliberations in Coreper
- 28 May 2026
- Deliberations in Council
- 4 Jun 2026
- Deliberations in Council working party
- 22 Jun 2026
- Deliberations in Council working party
- 3 Jul 2026
- Deliberations in Council working party · Council
- 4 Sept 2026
- Deliberations in Council working party · Council
Who is on it
The Parliament's rapporteurs, shadow rapporteurs and opinion rapporteurs currently on this file.
| Role | Name | Group | Country | Committee |
|---|---|---|---|---|
| Rapporteur | Tiemo Wölken | S&D | DE | JURI |
| Shadow rapporteur | Adrián Vázquez Lázara | Renew | ES | JURI |
| Shadow rapporteur | Emmanuel Maurel | The Left | FR | JURI |
| Shadow rapporteur | Javier Zarzalejos | EPP | ES | JURI |
| Shadow rapporteur | Marie Toussaint | Greens/EFA | FR | JURI |
| Rapporteur for opinion | Magdalena Adamowicz | EPP | PL | JURI |
Amendments
Tabled on 14 Nov 2023. The texts are in the amendment documents below.
By committee
- JURI108
By author
- Daniel Buda51
- Javier Zarzalejos38
- Marie Toussaint19
Amendments each member tabled or co-signed.
By article
- Recital 243
- Article 28 – paragraph 3 – point c2
- Article 29 – paragraph 32
- Article 29 – paragraph 52
- Article 32 – paragraph 12
- Article 35 – paragraph 11 a (new)2
- Article 35 – paragraph 2 – point j a (new)2
- Article 35 – paragraph 2 – point n2
- Article 44 – paragraph 22
- Article 57 – paragraph 22
ShowHide 20 more provisions
- Article 8 – paragraph 1 – point d a (new)2
- Recital 132
- Recital 32
- Recital 52
- Recital 602
- Recital 82
- Recital 92
- Article 11 – paragraph 1 a (new)1
- Article 11 – paragraph 1 – point f a (new)1
- Article 15 – paragraph 1 – point a1
- Article 15 – paragraph 1 – point c a (new)1
- Article 16 – paragraph 21
- Article 18 – paragraph 2 a (new)1
- Article 2 – paragraph 1 – point 12 a (new)1
- Article 20 – paragraph 11
- Article 23 – paragraph 11
- Article 24 – paragraph 11
- Article 24 – paragraph 21
- Article 24 – paragraph 31
- Article 24 – paragraph 5 a (new)1
Covers 48 of the 108 amendments.
Documents
Newest first. Each opens at its source.
- Text adopted · T9-0099/2024Parliament · 27 Feb 2024
- Report · A9-0022/2024Parliament · 24 Jan 2024
- Amendments · PE756.105Parliament · 9 Nov 2023
- Report · PE753.704Parliament · 13 Oct 2023
- Committee opinion · PE756.057Parliament · 13 Oct 2023
- Proposal · COM(2023)0231Commission · 27 Apr 2023
- Text adopted · SP(2024)270Parliament
Summary
GeneratedThis recast regulation harmonizes supplementary protection certificates across the EU, extending market exclusivity for patented medicinal products. It aims to balance legal certainty for pharmaceutical innovators with public health objectives and timely access to medicines.
What the workspace adds on this file
Everything above is the public record. Subscribers see this page with their own layer on top.
Why it matters to you
What moved
Your contacts on it
A first draft
Sources: EP Legislative Observatory · EU Law Tracker. Record as of 14 Sept 2026. Something wrong on this page? Report an error.
Request access
See this file with your own layer on top: why it matters to you, your contacts on it and a first draft. We’ll schedule a 20-minute walkthrough.
EU-hosted · GDPR-compliant · Trust Center →
By submitting, you agree to our privacy policy.